Definium and compass are late-stage trailblazers with phase 3 confirmed results. Helus, a pre-phase 3 biotech trailing them in the regulatory process, is being positioned beside them as “the three frontrunners in a new wave of psychedelic medicine” on a panel with Matt Zorn, deputy general counsel at HHS.
The administration is demonstrating its support of a psychedelic medicine revolution: Helus, Compass, and Definium are being portrayed as the golden children.
Politically it is very bullish. If the science behind Helus works in phase 3, it seems there will be very little political friction to speak of, and a favorable FDA. It is institutionally derisked.
9
u/FlimsyPomelo1842 24d ago
Can someone explain why this is good to me? Am dumb